Yüklüyor......
Cross-validation of optimized composites for preclinical Alzheimer's disease
INTRODUCTION: We discuss optimization and validation of composite end points for presymptomatic Alzheimer's disease clinical trials. Optimized composites offer hope of substantial gains in statistical power or reduction in sample size. But there is tradeoff between optimization and face validit...
Kaydedildi:
| Yayımlandı: | Alzheimers Dement (N Y) |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5527287/ https://ncbi.nlm.nih.gov/pubmed/28758145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2016.12.001 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|